Statins Not Static, Reddy’s Ready to Win December 28, 2016 U.S. imports of statins, used to primarily to manage cholesterol, increased 14% in November on a year earlier. Crestor and its generic versions jumped 480% on a year earlier after the end of its patent in April. It took market share from generic Pravachol, which saw imports fall 35% to their l... Read more →
Statin Imports Accelerate After Crestor Passes Its Crest November 21, 2016 U.S. imports of the anti-cholesterol drugs known as statins increased 40% in October on a year earlier. This was their fastest growth since January and the highest level of imports for the month since at least 2007. This was driven by generic versions of AstraZeneca’s Crestor being available s... Read more →